Header image

THANZ Presidential Symposium

Tracks
THANZ
Monday, October 19, 2026
10:30 AM - 12:00 PM
516

Speaker

Agenda Item Image
Dr Helen Lavrukhina
Haematology Trainee
Princess Alexandra Hospital

Upfront mycophenolate in newly diagnosed ITP is highly effective and well tolerated with durable responses

10:30 AM - 10:45 AM

Biography

Helen is a clinical Haematology trainee currently working at pathology Queensland’s central laboratory but has worked across the state and endeavours to work across the country, with an interest in both malignant and non-malignant Haematology particularly in immune cytopenias and general stream.
Agenda Item Image
Dr Rowena Brook
Haematologist
Northern Health

Use of data-independent mass spectrometry (DIA-MS) to identify plasma proteomic profiles associated with major adverse cardiovascular events in chronic kidney disease patients

10:45 AM - 11:00 AM

Biography

Dr Rowena Brook, MBBS, FRACP, FRCPA is an early career clinician-researcher in thrombosis and haemostasis. She is a PhD candidate with The University of Melbourne at the Northern Health Clinical School and a recipient of the Heart Foundation Postgraduate Scholarship. Rowena is also a consultant haematologist at Northern Health.
Agenda Item Image
Miss Huiwen Zhao
PhD Candidate
University of Sydney

ERp57 regulates Von Willebrand factor production

11:00 AM - 11:15 AM

Biography

Huiwen (Wendy) Zhao is a PhD candidate at the University of Sydney researching thrombosis mechanisms. Her work investigates ERp57 regulation of von Willebrand factor (vWF) expression. She obtained First Class Honours and the Dean's Award, and is supported by a full PhD scholarship from the University of Sydney.
Agenda Item Image
Dr Hannah Stevens
Haematologist
Royal Hobart Hospital

Persistent rural inequities in anticoagulation management for atrial fibrillation in the DOAC era

11:15 AM - 11:30 AM

Biography

Dr Hannah Stevens is a clinician-researcher and haematologist whose work focuses on thrombosis, haemostasis, and anticoagulation. Based at the Baker Heart and Diabetes Institute and Royal Hobart Hospital, she undertakes translational and population-based research using large-scale linked datasets and multi-omic approaches to improve personalised thrombosis and anticoagulation care.
Agenda Item Image
Mr Yuyang Song
PhD Student
Baker Heart and Diabetes Institute / University of Melbourne

Single-dose self-amplifying mRNA encoding an activated platelet-specific scFv provides thromboprophylaxis for one week

11:30 AM - 11:45 AM

Biography

Mr. Yuyang Song is a PhD candidate at Melbourne Medical School and the Baker Heart and Diabetes Institute. His research focuses on developing safer and longer-lasting therapies for cardiovascular disease, particularly thrombosis prevention without increasing bleeding risk. The work presented represents a chapter of his recently submitted PhD thesis.
Dr Ke Xu
PhD Candidate
ANZAC Research Institute

High-throughput flow cytometry platelet functional phenotyping for diagnosis of bleeding disorders

11:45 AM - 12:00 PM

Biography

Dr Ke Xu is a PhD candidate at the ANZAC Research Institute, and a clinical/laboratory haematologist. His research interests incude thrombosis biomarker in myeloproliferative neoplasms and inherited platelet disorders.
Agenda Item Image
Dr Danny Hsu
Staff Specialist
Liverpool Hospital

Chairperson

Biography

Dr David Connor
Post-doctoral Research Scientist
St Vincent's Hospital, Sydney

Chairperson

Biography

loading